Document is current
Any future updates will be listed below
-
Authors
Xu, Chenqi
Pan, Kunming
Li, Jie
Li, Yang
Jin, Shi
Shi, Yiqin
Teng, Jie
Ding, Xiaoqiang
Xu, Xialian
Liu, Hong
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82000706, 82204520)
China International Medical Foundation (No.Z-2021-46-2101)
The Chinese Pharmaceutical Association (No.CPA-Z05-ZC-2023-003)
Shanghai Pharmaceutical Association (No.(2023)04)
Shanghai Clinical Research Center for Kidney Disease (22MC1940100)
Shanghai Municipal Key Clinical Specialty (shslczdzk02501)
Natural Science Foundation of Shanghai (23ZR1411200)
- License Information
-
More Information
Article History
Received: 23 May 2024
Accepted: 24 August 2024
First Online: 14 September 2024
Declarations
:
: This study procedures were reviewed and approved by the Ethics Committee of Zhongshan Hospital, Fudan University (approval number: B2021-067R), and in compliance with the ethical principles established in the Declaration of Helsinki.
: The authors declare no competing interests.
